An Updated Meta-Analysis of Clinical Trials and Observational Studies of Intravascular Ultrasound- versus Angiography-guided Left Main Stenting

Authors

  • Nimra Ashraf National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  • Muhammad Ahmed Ilyas National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  • Jaghat Ram National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  • Ejaz Ul Haq National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  • Zaryab Ahmed Khuwaja National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  • Gohar Riaz National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
  • Ahmed Raheem Aga Khan University Karachi, Pakistan

DOI:

https://doi.org/10.47144/phj.v56i3.2596

Abstract

Objectives: This updated meta-analysis aimed to consolidate clinical evidence comparing the clinical outcomes of intravascular ultrasound (IVUS)-guided LMCA stenting versus conventional angiography-guided LMCA stenting.

Methodology: We included “randomized controlled trials” and “observational studies” published in peer-reviewed English language journals that compared the clinical outcomes of LMCA revascularization using “drug-eluting stents (DES)” via “IVUS-guided” versus “angiography-guided” stenting. The primary outcome of interest was “major adverse cardiovascular events (MACE)”, while secondary outcome variables included “all-cause mortality”, “myocardial infarction (MI)”, “target vessel/lesion revascularization (TVR/TLR)”, and “stent thrombosis (ST)”. Risk ratios (RRs) for each outcome variable were calculated using the “Mantel-Haenszel method”.

Results: The analysis included nine studies involving a total of 5,344 patients, with 2,282 undergoing “IVUS-guided” LMCA stenting and 3,062 undergoing “angiography-guided” LMCA stenting. “IVUS-guided” LMCA stenting showed a significant reduction in the risk of MACE compared to “angiography-guided” LMCA stenting, with a RR of 0.46 [95% CI: 0.27 - 0.79]. However, a high level of heterogeneity (I2=94%; p<0.01) was observed among the included studies. Additionally, “IVUS-guided” LMCA stenting was associated with significant reductions in all-cause mortality, MI, and ST, with RRs of 0.38 [0.21 - 0.66], 0.45 [0.26 - 0.77], and 0.24 [0.10 - 0.57], respectively. There was no statistically significant difference in TVR/TLR between “IVUS-guided” and “angiography-guided” LMCA stenting, with an RR of 0.64 [0.27 - 1.51].

Conclusion: “IVUS-guided” LMCA revascularization using DES was associated with a lower risk of MACE, death, MI, and ST compared to conventional “angiography-guided” LMCA stenting.

Downloads

Download data is not yet available.

Downloads

Published

2023-09-30

How to Cite

1.
Ashraf N, Ilyas MA, Ram J, Haq EU, Khuwaja ZA, Riaz G, Raheem A. An Updated Meta-Analysis of Clinical Trials and Observational Studies of Intravascular Ultrasound- versus Angiography-guided Left Main Stenting. Pak Heart J [Internet]. 2023Sep.30 [cited 2024Nov.22];56(3):224-30. Available from: https://pakheartjournal.com/index.php/pk/article/view/2596

Issue

Vol. 56 No. 3 (2023): Pakistan Heart Journal

Section

Original Article

License

Copyright (c) 2023 Pakistan Heart Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.

Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/